AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

LEXINGTON, Mass.–(BUSINESS WIRE)–May. 29, 2012–
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William
, AMAG’s new chief executive officer, will present at two investor
conferences in June. The presentations will include a company overview
and a review of the company’s growth opportunities.

The presentations will take place as follows:

  • June 4, at 9:30 a.m. EDTJefferies 2012 Global Healthcare Conference
    in New York City; and
  • June 6, at 2:40 p.m. PDTGoldman Sachs 33rd Annual Global
    Healthcare Conference in Rancho Palos Verdes, California.

A live webcast of each presentation will be accessible through the
Investors section of the company’s website at
Following the conferences, the webcasts will be archived on the AMAG
Pharmaceuticals, Inc.
website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on the development and commercialization of a therapeutic iron compound
to treat iron deficiency anemia. For additional company information,
please visit

Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303